BeOne Medicines (BEIGF) Inventory Average (2017 - 2026)

BeOne Medicines (BEIGF) has 10 years of Inventory Average data on file, last reported at $644.9 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $644.9 million, up 30.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $644.9 million (up 30.33% YoY), and the FY2025 annual result was $551.6 million, up 21.08% from the prior year.
• Inventory Average rose to $644.9 million in Q1 2026 per BEIGF's latest filing, from $570.0 million in the prior quarter.
• Over five years, Inventory Average peaked at $644.9 million in Q1 2026 and troughed at $244.1 million in Q1 2022.
• A 5-year average of $402.9 million and a median of $431.7 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2025: Inventory Average soared 200.9% in 2022, then gained 12.01% in 2025.
• A 5-year view of Inventory Average shows it stood at $286.6 million in 2022, then increased by 27.87% to $366.5 million in 2023, then rose by 26.41% to $463.3 million in 2024, then rose by 23.01% to $570.0 million in 2025, then advanced by 13.15% to $644.9 million in 2026.
• Business Quant data shows BEIGF's Inventory Average at $644.9 million in Q1 2026, $570.0 million in Q4 2025, and $517.3 million in Q3 2025.